This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Sep 7;73(5):857-858.

doi: 10.1093/cid/ciab150.

Fluoroquinolones: Friends or Foes?

Monica V Mahoney¹, Kyleen E Swords²

Affiliations

Affiliations

¹ Department of Pharmacy; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
² Division of Infectious Diseases; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

PMID: 34492696
DOI: 10.1093/cid/ciab150

Comment

Fluoroquinolones: Friends or Foes?

Monica V Mahoney et al. Clin Infect Dis. 2021.

. 2021 Sep 7;73(5):857-858.

doi: 10.1093/cid/ciab150.

Authors

Monica V Mahoney¹, Kyleen E Swords²

Affiliations

¹ Department of Pharmacy; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
² Division of Infectious Diseases; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

PMID: 34492696
DOI: 10.1093/cid/ciab150

No abstract available

PubMed Disclaimer

Comment on

Safety and Tolerability of Fluoroquinolones in Patients with Staphylococcal Periprosthetic Joint Infections.
Vollmer NJ, Rivera CG, Stevens RW, Oravec CP, Mara KC, Suh GA, Osmon DR, Beam EN, Abdel MP, Virk A. Vollmer NJ, et al. Clin Infect Dis. 2021 Sep 7;73(5):850-856. doi: 10.1093/cid/ciab145. Clin Infect Dis. 2021. PMID: 33606003

Publication types

Actions

MeSH terms

Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems